Mangoceuticals merger partner Nuclea agrees to buy Moltex nuclear technology assets in cash

Reuters2026/08/13 20:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Mangoceuticals merger partner Nuclea Energy signed a definitive deal to buy Moltex Energy’s advanced nuclear technology assets.
Asset purchase targets SSR-W molten salt reactor technology, WATSS spent-fuel recycling process, related development materials, and an 80-patent portfolio.
Cash consideration only, subject to adjustments tied to defined external debts; Moltex is in administration.
Portfolio reflects more than C$96 million of prior private investment and public funding; SSR-W completed Phase 1 of Canada’s CNSC vendor design review.
Closing targeted within three months, subject to conditions including UK national security review and customary consents.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608131605PRIMZONEFULLFEED9809909) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Mangoceuticals merger partner Nuclea agrees to buy Moltex nuclear technology assets in cash

You may also like

Crypto prices